Does BISOPROLOL Cause Basal cell carcinoma? 124 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Basal cell carcinoma have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.5% of all adverse event reports for BISOPROLOL.
124
Reports of Basal cell carcinoma with BISOPROLOL
0.5%
of all BISOPROLOL reports
9
Deaths
73
Hospitalizations
How Dangerous Is Basal cell carcinoma From BISOPROLOL?
Of the 124 reports, 9 (7.3%) resulted in death, 73 (58.9%) required hospitalization, and 16 (12.9%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which BISOPROLOL Alternatives Have Lower Basal cell carcinoma Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB